Signs of Drug Use
Street Drugs
Prescription Drugs
Prescription Narcotics
Prescription Stimulants
Prescription Depressants
Illicit Drugs
Drug Abuse in the Workplace
Scientific Research
Signs of Drug Use
Personality
- Becomes disrespectful – is verbally and physically abusive
- Is angry a lot, acts paranoid or confused, or suffers from extreme mood swings
- Seems depressed and less out-going than usual
- Is secretive and lies about what he is doing and where he is going
- Is stealing or “losing” possessions he used to value
- Seems to have a lot of money, or is always asking for money
- Withdraws from the family and family activities
Physical Appearance
-
Not taking care of hygiene and grooming
- Not sleeping or sleeping too much
- Loss of appetite
- Weight loss or weight gain
- Too hyperactive or too little energy
Social activity/school performance
-
Drops old friends and activities
- Is skipping school
- Loses interest in school work and is getting low grades
- Is sleeping in class
- Loses concentration and is having trouble remembering things
Top
Street Drugs
According to the latest estimates available, in 2004, 19.1 million Americans, or 7.9 percent of the population aged 12 or older, were current illicit drug users, current use meaning use of an illicit drug during the month prior to the survey interview. 1
22.5 million Americans aged 12 or older in 2004 were classified with past year substance dependence or abuse (9.4 percent of the population), about the same number as in 2002 and 2003. Of these, 3.4 million were classified with dependence on or abuse of both alcohol and illicit drugs, 3.9 million were dependent on or abused illicit drugs but not alcohol, and 15.2 million were dependent on or abused alcohol but not illicit drugs.2
References:
1, 2, 3: SAMHSA, 2004 National Survey on Drug Use and Health, September 2005.
Top
Prescription Drugs
The use and abuse of prescription medication non-medically is an issue equally as serious as the use of illegal drugs. These are drugs, regardless of whether they are prescribed or diverted, there is potential for abuse. Some medications have properties related to other drugs that are legal and some have chemical structures related to those of illegal drugs. The addictive potential for some of these drugs is the same as that for heroin or methamphetamine, but, because they are prescribed by doctors, they are perceived as safe. A new trend among young people is called Pharming Parties where they get together at a party and exchange prescription medications and get high on either one or multiple types of medications. Medications that appear at these types of parties are of various types of stimulants, narcotics, and depressants.
Top
Prescription Narcotics
Prescription narcotics, also known as narcotic analgesics or opioids, are among the most widely used and abused medicines today. When used as directed, prescription narcotics can alleviate varying degrees of pain. Morphine is typically used before or after surgery to alleviate severe pain. Oxycodone and hydrocodone are used to alleviate moderate to severe pain. Codeine is prescribed to treat mild pain and is also prescribed to alleviate coughing.
According to NIDA, opioids (prescription narcotics) act by attaching to specific proteins called opioid receptors, which are found in the brain, spinal cord, and gastrointestinal tract. When these compounds attach to certain opioid receptors, they can effectively change the way a person experiences pain.
In addition, opioid medications can affect regions of the brain that mediate what we perceive as pleasure, resulting in the initial euphoria that many opioids produce. They can also produce drowsiness, cause constipation, and, depending upon the amount taken, depress breathing. Taking a large single dose could cause severe respiratory depression or death. Opioids may interact with other medications and are only safe to use with other medications under a physician’s supervision. Typically, they should not be used with substances such as alcohol, antihistamines, barbiturates, or benzodiazepines. 2
References:
1: NSDUH/SAMHSA, The NSDUH Report: Non-medical Use of Prescription Pain Relievers, May 2004.
2: NIDA, NIDA Info Facts: Prescription Pain and Other Medications, February 2005.
Long-term use can lead to physical dependence – the body adapts to the presence of the substance and withdrawal symptoms occur if use is reduced abruptly. This can also include tolerance, which means that higher doses of a medication must be taken to obtain the same initial effects. Note that physical dependence is not the same as addiction – physical dependence can occur even with appropriate long-term use of opioid and other medications. Addiction, is defined as compulsive, often uncontrollable drug use in spite of negative consequences. 5 Those taking narcotics should be supervised when stopping use in order to reduce or avoid withdrawal symptoms. Withdrawal symptoms include restlessness, muscle and bone pain, insomnia, diarrhea, vomiting, cold flashes with goose bumps, and involuntary leg movements. 1
References:
1,5: NIDA, NIDA Info Facts: Prescription Pain and Other Medications, February 2005.
2: NSDUH/SAMHSA, The NSDUH Report: Non-medical Use of Prescription Pain Relievers, May 2004.
3: Drug Abuse Warning Network, The DAWN Report: Narcotic Analgesics: 2002 Update, September 2004
4: SAMHSA, The DASIS Report: Treatment Admissions Involving Narcotic Painkillers: 2002 Update, July 23, 2004
Oxycodone (OxyContin®)
Oxycodone is a narcotic prescribed to relieve pain and is twice as potent as morphine. There are many variations of enzoylec products on the market but of those, OxyContin, Percocet, and Percodan are used and abused most frequently. OxyContin® ( enzoylec hydrochloride ER) is a timed-release version of enzoylec and, until recently, was the only extended release version of enzoylec. In March 2004, a generic version became available by prescription. The generic version quickly became available on the illegal drug market and may pose a significant threat because it is only available in 80 mg. doses, whereas OxyContin® is available in 10, 20, 40 and 80 mg. doses. Oxycodone HCI ER (the generic version) comes in small oval, light green tablets. One side of the tablet is labeled “93”, the other side is labeled “33”. 1 Used as a substitute for heroin, abusers use the drug to relieve pain, alleviate withdrawal symptoms, and gain euphoric effects typically associated with use of the drug.
Signs of enzoylec use include nausea, drowsiness, impaired coordination, weakness, confusion, small pupils, and clammy skin. Other general effects include muscle relaxation, lowered blood pressure, lowered heart rate, and lowered respiratory rate. Possible negative effects include an allergic reaction, difficulty breathing, swelling of the face, hives, seizures, loss of consciousness, and coma. Effects of long term use include constipation, respiratory depression, physical tolerance and psychological and physical dependence. Withdrawal symptoms include restlessness, muscle and bone pain, insomnia, diarrhea, vomiting, cold flashes, and involuntary leg movements.
References:
1: DEA, DRUG ALERT: Generic OxyContin® Emerges as New Threat.
2: NDIC, National Drug Threat Assessment 2004, Product No. 2004-Q0317-002, April 2004.
3: NDSUH Report: Non-medical Oxycodone Users: A Comparison with Heroin Users, January 21, 2005
4: SAMHSA, The DAWN Report: Oxycodone, Hydrocodone, and Polydrug Use in 2002, July 2004
Hydrocodone
Hydrocodone is a legal opiate prescribed for pain that has qualities similar to morphine. There are over 200 medications that contain hydrocodone, and in the United States, over 20 tons of hydrocodone are used annually. Hydrocodone is available in pill and syrup forms. Not only is abuse of hydrocodone dangerous and addictive, high doses of acetaminophen can severely damage the liver.
Signs of hydrocodone use include nausea, drowsiness, impaired coordination, weakness, confusion, and small pupils. Other general effects include muscle relaxation, lowered blood pressure, lowered heart rate, and lowered respiratory rate. An allergic reaction, difficulty breathing, closing of the throat, facial swelling, hives, seizures, loss of consciousness, and coma are also possible consequences of hydrocodone use. Long term effects include constipation, dryness of the mouth, respiratory depression, physical tolerance, and psychological and physical dependence.
Brand names for hydrocodone products include Anexsia®, Hycodan®, Hycomine®, Lorcet®, Lortab®, Tussionex®, Tylox®, Vicodin®, and Vicoprofen®.
Hydromorphone
Hydromorphone (Dilaudid®) is marketed in tablets (2, 4 and 8 mg), rectal suppositories, oral solutions, and injectable formulations. All products are Schedule II. Its analgesic potency is from two to eight times that of morphine, but it is shorter acting and produces more sedation than morphine. Much sought after by narcotic addicts, hydromorphone is usually obtained by the abuser through fraudulent prescriptions or theft.
Morphine
Morphine is the principal constituent of opium and can range in concentration from 4 to 21 percent. Commercial opium is standardized to contain 10-percent morphine. In the United States, a small percentage of the morphine obtained from opium is used directly (about 15 tons): the remaining is converted to codeine and other derivatives (about 120 tons). Morphine is one of the most effective drugs known for the relief of severe pain and remains the standard against which new analgesics are measured. Like most narcotics, the use of morphine has increased significantly in recent years.
Morphine is marketed under generic and brand name products including MS-Contin®, Oramorph SR®, MSIR®, Roxanol®, Kadian®, and RMS®. Morphine is used parenterally (by injection) for preoperative sedation, as a supplement to anesthesia, and for analgesia. It is the drug of choice for relieving pain of myocardial infarction and for its cardiovascular effects in the treatment of acute pulmonary edema. Traditionally, morphine was almost exclusively used by injection. Today, morphine is marketed in a variety of forms, including oral solutions, immediate and sustained-release tablets and capsules, suppositories, and injectable preparations. In addition, the availability of high-concentration morphine preparations (i.e., 20-mg/ml oral solutions, 25-mg/ml injectable solutions, and 200-mg sustained-release tablets) partially reflects the use of this substance for chronic pain management in opiate-tolerant patients.
Fentanyl
First synthesized in Belgium in the late 1950’s, fentanyl, with an analgesic potency of about 80 times that of morphine, was introduced into medical practice in the 1960’s as an intravenous anesthetic under the trade name of Sublimaze®. Thereafter; two other fentanyl analogues were introduced, alfentanil (Alfenta®), and ultra-short (5-10 minutes) acting analgesic, and sufentanil (Sufenta®, an exceptionally potent analgesic (5 to 10 times more potent than fentanyl) for use in heart surgery. Today, fentanyls are extensively used for anesthesia and analgesia. Duragesic®, for example, is a fentanyl transdermal patch used in chronic pain management, and Actiq® is a solid formulation of fentanyl citrate on a stick that dissolves slowly in the mouth for transmucosal absorption. Actiq® is intended for opiate-tolerant individuals and is effective in treating breakthrough pain in cancer patients. Carfentanil (Wildnil®) is an analogue of fentanyl with an analgesic potency 10,000 times that of morphine and is used in veterinary practice to immobilize certain large animals.
Illicit use of pharmaceutical fentanyls first appeared in the mid-1970s in the medical community and continues to be a problem in the United States. The biological effects of the fentanyls are indistinguishable from those of heroin, with the exception that the fentanyls may be hundreds of times more potent.
Top
Prescription Stimulants
Stimulants are drugs that increase alertness and energy. Stimulants are typically prescribed for attention-deficit hyperactivity disorder, however, are also prescribed for narcolepsy and some forms of depression. Two of the most common prescribed stimulants are Ritalin® (methylphenidate) and Adderall® (dextroamphetamine). These two products are also the most commonly abused stimulants.
Stimulants, such as dextroamphetamine (Adderall
®, Dexedrine
®) and methylphenidate (Ritalin®, Methylin
®, Concerta
®) have chemical structures that are similar to a family of key brain neurotransmitters called monoamines, which include norepinephrine and dopamine. Stimulants increase the amount of these chemicals in the brain. This, in turn, increases blood pressure and heart rate, constricts blood vessels, increases blood glucose, and opens up the pathways of the respiratory system. In addition, the increase in dopamine is associated with a sense of euphoria that can accompany the use of these drugs.
1
References:
1: NIDA Research Report Series, Prescription Drugs: Abuse and Addiction, NIH Publication Number 01-4881, July 2001.
2: SAMHSA, The NSDUH Report: Stimulant Use in 2003, February 4, 2005.
Ritalin® AND Adderall®
Both Ritalin® (methylphenidate) and Adderall® (dextroamphetamine) are the two most commonly abused prescription stimulants. Ritalin and Adderall are typically prescribed to treat attention deficit disorders (ADHD and ADD) but are often abused by high school and college students looking for drugs to keep them awake in school or while preparing for tests. Because they are both stimulants, the effects of both are similar to that of cocaine or methamphetamine when abused. Signs of use include dilated pupils, sweating, dry mouth, and flushed skin. Other general effects include increased energy, increased body temperature, elevated heart rate, and elevated blood pressure. When taken in large doses, dangerously high body temperature, irregular heartbeat, paranoia, cardiovascular failure, and lethal seizures are possible. The diversion of Adderall® and Ritalin® appears to be increasing, largely because of an increasing number of patients selling their legitimately prescribed supplies to abusers.
References:
1: NDIC, National Drug Threat Assessment 2004, Product No. 2004-Q0317-002, April 2004.
2: The Partnership for a Drug-Free America, Partnership Attitude Tracking Study, 2002.
Top
Prescription Depressants
Prescription depressants have effects that are similar to the effects of alcohol, but can have more or less potent effects dependent on the dose and type of drug taken. Depressants are typically used to treat anxiety disorders and short-term sleep disorders.
CNS depressants can be divided into two groups, based on their chemistry and pharmacology:
- Barbiturates, such as mephobarbital (Mebaral®) and pentobarbitalsodium (Nembutal), which are used to treat anxiety, tension, and sleep disorders.
- Benzodiazepines, such as diazepam (Valium®), chlordiazepoxide HCI (Librium®), and alprazolam (Xanax®), which can be prescribed to treat anxiety, acute stress reactions, and panic attacks. Benzodiazepines that have a more sedating effect, such as estazolam (ProSom®), can be prescribed for short-term treatment of sleep disorders. 1
Depressants, particularly benzodiazepines, are widely available and abused in all regions of the United States. Depressants are prescribed for legitimate purposes; they are abused primarily for their sedative and euphoric effects as well as to enhance the intoxication of alcohol, to modulate the euphoric effects of opiods, and to modulate the euphoric effects of opiods, and to modulate the adverse consequences of stimulant abuse.
Prescription depressants can be addictive, especially if misused, and withdrawal is a common ramification with those who abuse the drugs. Discontinuing prolonged use of high doses of CNS depressants can lead to withdrawal. Because they work by slowing the brain’s activity, a potential consequence of abuse is that when one stops taking a CNS depressant, the brain’s activity can rebound to the point that seizures can occur. Someone thinking about ending their use of a CNS depressant, or who has stopped and is suffering withdrawal, should speak with a physician and seek medical treatment.
A large percentage of people entering treatment for narcotic or cocaine addiction also report abusing benzodiazepines. Alprazolam® and Diazepam® are the two most frequently encountered benzodiazepines on the illicit market
CNS depressants should be used with other medications only under a physician’s supervision. Typically, they should not be combined with any other medication or substance that causes CNS depression, including prescription pain medicines, some over-the-counter cold and allergy medications, or alcohol. Using CNS depressants with these other substances – particularly alcohol – can slow breathing, or slow both the heart and respiration, and possibly lead to death. 2
References:
1: NIDA InfoFacts, Prescription Pain and Other Medications, February 2005.
2: NIDA InfoFacts, Prescription Pain and Other Medications, February 2005.
Royhypnol®
Rohypnol® (flunitrazepam hydrochloride) is a powerful benzodiazepine sedative reportedly 10 times stronger than Valium®. Rohypnol® is used as a preoperative sedative and to treat sleeping disorders. Rohypnol® is illegal in the United States but is legal in over 70 other countries and is manufactured primarily in Europe and Latin America. In the United States, the availability of Rohypnol® is generally low and its use is most prominent in the states near the U.S. – Mexico border. Rohypnol® is available in tablet and injectable forms but the tablet form is most commonly used
Signs of use include poor coordination, sedation, fatigue, confusion, and dizziness. Other general effects of use include decreased heart rate and blood pressure, muscle relaxation, memory impairment, amnesia, nightmares, and tremors. Long term effects include physical and psychological dependence. Signs of overdose include loss of muscle control, loss of consciousness, and anterograde amnesia.
References:
1: NIDA, InfoFacts, Club Drugs, March 2005.
2: ONDCP Fact Sheet Rohypnol®, February 2003.
DXM
DXM (dextromethorphan) is a cough-suppressing ingredient in a variety of over the counter cold and cough medications including syrup, tablets, and lozenges. DXM powder has also begun to appear on the internet. DXM, a synthetic drug that chemically is similar to morphine, was approved by the Food and Drug Administration as a cough suppressant in 1954. In the 1970’s, manufacturers began putting DXM in cough syrup to replace codeine
There are more than 120 different products on the market that contain DXM. At the doses recommended for treating coughs (1/6 to 1/3 ounce of medication, containing 15 mg to 30 mg dextromethorphan), the drug is safe and effective. At much higher doses (4 or more ounces), dextromethorphan produces dissociative effects similar to those of PCP and Ketamine. The effects of excessive DXM use can last for up to 6 hours and include loss of muscle control, slurred speech, diarrhea, rash, abdominal pain, fever and sweating, nausea and vomiting, high blood pressure, headache, numbness of fingers and toes, loss of consciousness, mania, brain damage, coma, cerebral hemorrhages, seizures, stroke and death.
Over-the-counter products that contain DXM often contain other ingredients such as acetaminophen, chlorpheniramine, and guaifensin. Large dosages of acetaminophen can cause liver damage; large dosages of chlorpheniramine can cause increased heart rate, lack of coordination, seizures, and coma; and large dosages of guaifenesin can cause vomiting. Some first-time users may not abuse DXM repeatedly if they experience negative side effects – such as vomiting – commonly associated with the other ingredients contained in over-the-counter DXM medications. Nonetheless, some DXM abusers “robo shake”, a practice whereby they drink a large amount of couch syrup containing DXM and then force themselves to vomit so as to absorb enough DXM through the stomach lining to achieve the desired effect while expelling the other ingredients. Some more experienced abusers use a chemical procedure to extract the DXM from the other ingredients contained in cough syrup to avoid such side effects. (This procedure cannot be used on DXM products sol in non-liquid form.) 1
References:
1,2: NDIC, Intelligence Bulletin: DXM, Document ID 2004-L0424-029, October 2004.
Top
Illicit Drugs
Ecstasy (MDMA)
MDMS (3,4-methylenedioxymethamphetamine) is a synthetic drug with both stimulant and hallucinogenic qualities. MDMA (ecstasy) is sometimes referred to as a “designer drug”. A designer drug is one that is either a copycat of another drug (a variation of it) or a synthetic compound of two or more drugs. MDMA is the latter – its chemical structure is similar to methamphetamine, methylenedioxyamphetamine (MDA), and mescaline
MDMA is typically distributed in urban areas, beach resorts, at or near college universities, raves, dance clubs, and bars. Most MDMA distribution occurs in urban and suburban areas; however, much of the increased distribution is occurring in midsize cities with large college populations.
Because of MDMA’s popularity not only is production increasing around the world but tablets and capsules being sold as “Ecstasy” are increasingly not pure MDMA. The growing number of pills and capsules being marketed as MDMA but containing drugs like methamphetamine, PCP, amphetamine, enzoyle, and PMA – with or without MDMA – has increased the dangers associated with MDMA use.
References:
1: NDIC, National Drug Threat Assessment, April 2004.
2: European Monitoring Centre for Drugs and Drug Addiction, The State of the Drugs Problem in the European Union and Norway, ISBN 92-9168-199-7, 2004.
3: NDIC, National Drug Threat Assessment, January 2006.
Ocotea Cymbarum
Forensic chemists have reported that ocotea cymbarum has been discovered at several clandestine laboratories in the Northeast. Ocotea cymbarum is an essential oil – distilled from the trunk bark of a tropical tree native to Brazil, Colombia, and Paraguay – that typically contains between 80 and 94 percent safrole, a precursor for MDMA (3,4-methylenedioxymethamphetamine, also known as ecstasy) and MDA (3,4-methylenedioxyamphetamine). Ocotea cymbarum also is known as Brazilian sassafras oil but is sold under other names and spellings such as Ocotea cymbarum oil, Ocotea cynbarnum, Ocotea cymbarium and “Oil of Ocotea”. 2
References:
1: European Monitoring Council on Drugs and Drug Abuse.
2: NDIC Intelligence Alert, Narcotics Digest Weekly 2005: 4(41):1.
General effects of MDMA use include increased heart rate and blood pressure, increased body temperature, possible hyperthermia, jaw and teeth clenching, muscle tension, hypertension, dehydration, chills and or sweating, nausea, blurred vision, faintness, dizziness, confusion, insomnia, and paranoia. Long term effects of MDMA use include rash, depression, sleep disorders, drug craving, persistent elevation of anxiety, paranoia, aggressive and impulsive behavior
An ecstasy overdose is characterized by a rapid heart beat or high blood pressure, faintness, muscle cramping, panic attacks, and in more severe cases, loss of consciousness or seizures. Other adverse effects include nausea, hallucinations, chills, sweating, tremors, hyperthermia, tachycardia, breakdown of skeletal muscle with kidney failure, and blurred vision. Ecstasy users also report after-effects of anxiety, paranoia, and depression. Death has resulted from kidney or cardiovascular failure induced by hyperthermia and dehydration. 1
MDMA abuse may permanently inhibit the user’s ability to produce serotonin – a neurotransmitter that regulates mood, sleep, pain, emotion, and appetite – resulting in chronic depression and anxiety. 2
Because MDMA is a relatively new drug, pending advancement in research may discover other long term effects of MDMA use
Controlled studies in humans have shown that MDMA has potent effects on the cardiovascular system and on the body’s ability to regulate its internal temperature. Of great concern is MDMA’s adverse effect on the pumping efficiency of the heart – in the presence of MDMA, increased physical activity increases heart rate significantly, but the heart does not respond in its normal manner, which is to increase the efficiency with which it pumps blood. Since MDMA use is often associated with sustained, strenuous activity, such as dancing, MDMA’s effects on the heart could increase the risk of heart damage or other cardiovascular complications in susceptible individuals. 1
MDMA in its true form works in the brain by increasing the activity levels of at least three neurotransmitters (the chemical messengers of brain cells): serotonin, dopamine, and norepinephrine. Like amphetamines, MDMA causes these neurotransmitters to be released from their storage sites in neurons resulting in increased brain activity. Compared to the very potent stimulant, methamphetamine, MDMA causes greater serotonin release and somewhat lesser dopamine release. Serotonin is a neurotransmitter that plays an important role in regulation of mood, sleep, pain, emotion, appetite, and other behaviors. By releasing large amounts of serotonin and also interfering with its synthesis, MDMA causes the brain to become significantly depleted of this important neurotransmitter. As a result, it takes the human brain time to rebuild its serotonin levels. For people who take MDMA at moderate to high does, depletion of serotonin may be long-term.
These persistent deficits in serotonin are likely responsible for many of the persistent behavioral effects that the user experiences. There is a growing body of evidence that associates this serotonin loss in heavy MDMA users to confusion, depression, sleep problems, persistent elevation of anxiety, aggressive and impulsive behavior and selective impairment of some working memory and attention processes. 2
References:
1: Source: NIDA: Ecstasy: What We Know and Don’t Know About MDMA, A Scientific Review.
2: Source: Glen R. Hanson, D.D.S., Ph. D., Acting Director, NIDA: Statement for the Record 9/19/02, Research on MDMA.
STIMULANTS
Yaba
Thai for “crazy medicine”, Yaba tablets have overwhelmed Southeast Asia but availability in the United States and other areas of the world is limited. Yaba tablets are manufactured with varying amounts of caffeine and methamphetamine and are often stamped with the logos “wy” or “r”. Generally no larger than a pencil eraser, the tablets are sold in different colors and are sometimes flavored (grape, orange, vanilla). Tasting like candy, the tablets are obviously marketed to a young audience, particularly at raves or parties where ecstasy has been widely established.
References:
Source: DEA Intelligence Brief, April 2002.
Methamphetamine
Methamphetamine use can be lethal, addictive, and unpredictable. Methamphetamine has effects similar to those of amphetamine, yet the effects of methamphetamine are more damaging to the central nervous system.
Methamphetamine can cause a variety of cardiovascular problems. These include rapid heart rate, irregular heartbeat, increased blood pressure, and irreversible, stroke-producing damage to small blood vessels in the brain. Hyperthermia (elevated body temperature) and convulsions can occur with a methamphetamine overdose, and if not treated immediately, can result in death.
Chronic methamphetamine abuse can result in inflammation of the heart lining, and among users who inject the drug, damaged blood vessels and skin abscesses. Heavy users also exhibit progressive social and occupational deterioration. Psychotic symptoms (paranoia, delusions, mood disturbances) can sometimes persist for months or years after use has ceased. Over time, methamphetamine appears to cause reduced levels of dopamine, which can result in symptoms like those of Parkinson’s disease, a severe movement disorder.
Acute lead poisoning is another potential risk for methamphetamine abusers. A common method of illegal methamphetamine production uses lead acetate as a reagent. Production errors therefore may result in methamphetamine contaminated with lead. There have been documented cases of acute lead poisoning in intravenous methamphetamine abusers.2
References:
1,2: NIDA, Methamphetamine Abuse and Addiction, NIH Publication Number 02-4210, January 2002.
Meth Mouth
Meth mouth is caused by smoking methamphetamine, and to a lesser degree, inhaling the drug through the nostrils. The toxic and caustic ingredients involved in the making of methamphetamine – anhydrous ammonia (farm fertilizer), lithium (from batteries), drain cleaner, camp fuel, engine starter among other toxic ingredients are very acidic causing very aggressive erosion of tooth enamel.
Signs of methamphetamine use include dilated pupils, sweating and flushed skin, dry mouth, tremors, increased energy or hyperactivity, and clouded mental functioning. Other general effects include elevated heart rate, blood pressure, and respiratory rate; decreased appetite, alertness, aggression, paranoia, depression, and irritability. At high doses, hallucination and delusions have been reported. Long-term effects include strong psychological dependence and varying degrees of physical tolerance; malnutrition, skin abscesses, mood disturbances and psychosis; kidney and other tissue damage; cardiac and neurological damage including irregular heartbeat, increased blood pressure, inflammation of the heart lining and stroke-producing damage to small blood vessels in the brain.
Methamphetamine has many faces. Because of the various production methods, varying degrees of skill of the clandestine lab operator, and different chemicals used to manufacture methamphetamine, the finished product varies in color and texture. Pure methamphetamine is most commonly a shade of tan or white.
References:
1: NIDA, Research Report: Methamphetamine Abuse and addiction, NIH Publication Number 02-4210, January 2002.
2: SAMHSA, The NSDUH Report: Methamphetamine Use, Abuse, and Dependence: 2002, 2003, 2004, published September 16, 2005.
Crystal Meth
Crystal methamphetamine, commonly called glass or ice because of its appearance, is a colorless, odorless, large-crystal form of d-methamphetamine.
The effects of crystal meth are similar to those of powdered methamphetamine. Typically, crystal meth has a high level of purity and the effects can last 12 or more hours.
Cocaine
Cocaine is the most potent stimulant of natural origin and is one of the oldest identified drugs. The pure chemical, cocaine hydrochloride, has been an abused substance for more than 100 years, and coca leaves, the source of cocaine, have been ingested for thousands of years. Pure cocaine was first extracted from the leaf of the Erythroxylon coca bush, which grows primarily in Peru and Bolivia, in the mid-19th century. In the early 1900’s, it became the main stimulant drug used in tonics and elixirs that were developed to treat a wide variety of illnesses. Today, cocaine is not used medically because of its high potential for abuse and addiction.
Signs of cocaine use include blurred vision, dilated pupils, tremors and twitching, chest pain or pressure, and fever. In general, cocaine use causes an elevated heart rate, elevated blood pressure, elevated respiratory rate, decreased appetite, aggression, paranoia, depression, and irritability. At high doses, cocaine may produce hallucinations or delusions. Long term effects of use include a strong psychological dependence and varying degrees of physical tolerance. Eating disorders, malnutrition, impotence, seizures, strokes, severe withdrawal symptoms, and permanent damage to the nasal passage are also consequences of cocaine use. Cocaine-related deaths are often attributed to cardiac arrest or seizures followed by respiratory arrest.
There are two forms of cocaine: powdered cocaine and crack. The powdered, hydrochloride salt is the form of cocaine. Crack is cocaine that has not been neutralized by an acid to make the hydrochloride salt, and comes in a rock crystal form.
Wholesale cocaine is wrapped in plastic and taped for protection while in transit to the United States. Lab operators place markings on the “kilo bricks” or wrappings, identifying the lab operator or designating who the recipient should be. Some producers have used bar coding. Wholesale distributors typically purchase cocaine in kilogram or multi-kilogram allotments.
Colombian traffickers continue to dominate the movement of coca from the jungles of Bolivia and Peru to the large cocaine HCL conversion laboratories in southern Colombia. Much of the processing activities take place in the southern rain forests and eastern lowlands of Colombia. Also, cultivation occurs in areas of high insurgency that are effectively beyond the control of the Colombian government.
Cocaine is generally sold on the street as a fine, white, crystalline powder. Street dealers may dilute pure cocaine with inert substances such as lactose, inositol, mannitol cornstarch, and/or sugar, or with active drugs such as procaine or lidocaine (a chemically-related local anesthetic) or with other stimulants such as amphetamines.
References:
1: NDIC, National Drug Threat Assessment, January 2006.
2: Crack and Cocaine, NIDA InfoFacts, March 2005.
3: NIDA, Cocaine Abuse and Addiction, NIH Publication Number 99-4342, November 2004.
4: CIA, Coca Fact Sheet: A primer.
5: NDIC, National Drug Threat Assessment, January 2006.
Crack
Crack is derived directly from cocaine. The effects of crack are similar to those of cocaine yet they occur more rapidly and are more intense but do not last as long as a cocaine high. Smoking crack can cause severe chest pains with lung trauma and bleeding. Smoking crack also has a more rapid addiction potential.
Smoking crack delivers large quantities of the drug to the lungs, producing effects comparable to intravenous injection. These effects are felt almost immediately after smoking and are very intense, but do not last long.
References:
1: European Monitoring Centre for Drugs and Drug Addiction, The State of the Drugs Problem in the European Union and Norway, ISBN 92-9168-199-7, 2004.
2: 2005 Edition EMCDDA.
3: DEA Museum, “DEA History: 1985-1990: The Crack Epidemic”.
4: NDIC, National Drug Threat Assessment, January 2006.
Khat
Khat (pronounced “cot”), scientifically known as Catha Edulis, is a 2 to 12-foot flowering evergreen shrub native to East Africa and the Arabian Peninsula. For centuries the leaves of the Catha Edulis shrub have been consumed and chewing khat predates the use of coffee. Kat contains two scheduled substances, cathinone and cathine, both of which are stimulants.
Fresh khat leaves contain cathinone – a Schedule 1 drug under the Controlled Substances Act; however, the leaves typically begin to deteriorate after 36 hours, causing the chemical composition of the plant to break down. Once this occurs, the leaves contain cathine, a Schedule IV drug. Fresh khat leaves are glossy and crimson-brown in color, resembling withered basil. Deteriorating khat leaves are leathery and turn yellow-green in color.
Street terms for khat include Kat, Qat, Chat, Gat, Tohai, Tschat, Mirraa, African Salad, Bushman’s Tea, Catha, Abyssinian Tea, and Mairungi. Khat is often wrapped in banana leaves to preserve freshness. Recently, khat seizures have involved freeze-dried khat.
Common side effects include tachycardia, hypertension, insomnia, and gastric disorders. Chronic use can result in physical exhaustion, anorexia, violence, suicidal depression and khat can also induce manic behavior, hyperactivity and hallucinations.
Methcathinone
Methcathinone is known on the street as “Cat”. It is a structural analogue of methamphetamine and cathinone. Thought to be the up and coming drug of the 1980’s its popularity has declined.
Signs of use include dilated pupils, elevated body temperature, insomnia, tremors/muscle twitching, and headaches. Other general effects include increased heart rate, convulsions, restlessness, euphoric feelings, increased alertness, and hallucinations. Long term effects of use include delusions, paranoia, anxiety, depression, malnutrition, weight loss, dehydration, electrolyte imbalance, stomach pains, nausea, nose bleeds, destruction of nasal tissue, body aches, permanent brain damage, and death.
Amphetamine
Three drugs are jointly referred to as amphetamines – amphetamine, dextroamphetamine, and methamphetamine. All three are central nervous system stimulants and their chemical structures are so similar that it is difficult for users to tell them apart. Stimulants are a class of drugs that generally increase alertness, attention, and energy. Caffeine is a mild stimulant, cocaine is a potent stimulant, and MDMA (ecstasy) has stimulant-like attributes.
Street terms for amphetamine include P, Phet, Billy, Whizz, Sulph, and Base. Amphetamine is often taken with other drugs, in particular, MDMA (ecstasy).
Amphetamine is used medically as an aid in treating narcolepsy, some forms of depression, and Attention Deficit Hyperactivity Disorder (ADHD). However, due to the potential for abuse and addiction, other treatment methods are used more frequently. Brand name amphetamines include Adderall®, Desoxyn®, Dexedrine®, and DestroStat®.
In the United States, amphetamine or dextroamphetamine abuse is not common. However, in Europe , amphetamine abuse is widespread. Historically in Europe, amphetamine has been the drug most commonly used after cannabis. However, recent survey evidence suggests that the use of MDMA (ecstasy) now equals, or even exceeds, amphetamine use in some parts of Europe.1 Worldwide amphetamine production appears to be concentrated in Europe with 82% of the total amphetamine seized worldwide in 2003 coming from western Europe, in particular the Netherlands, followed by Poland and Belgium. 2.
Signs of amphetamine use include sweating, tremors, and dry mouth. In general, abusers of amphetamines may show signs of rapid and/or irregular heart rate, rapid breathing, high blood pressure, feelings of exhilaration, high energy, increased mental alertness, reduced appetite, and possible hallucinations. Long term effects include weight loss, loss of coordination, irritability, anxiousness, restlessness, delirium, panic, paranoia, impulsive behavior, aggressiveness, tolerance, addiction, brain damage, and heart failure. Signs of amphetamine overdose include restlessness, tremors, rapid breathing, confusion, vomiting, diarrhea, irregular heartbeat, and seizures. Withdrawal symptoms include depression, anxiety, stomach cramps, nausea, tremors (“the shakes”), and intense cravings.
References:
1,2: European Monitoring Centre for Drugs and Drug Addiction, The State of the Drugs Problem in Europe, ISBN 92-9168-227-6,2005.
NARCOTICS
Opium
The opium poppy (papaver somniferum) is the key ingredient for all narcotics. Opium is the milky latex fluid contained in the un-ripened seed pod of the poppy plant.
Although some narcotics are synthetic, even the synthetic drugs are made to replicate the makeup of ingredients extracted from the opium poppy.
Opium consists of morphine, codeine, thebaine and other substances. Opium (specifically its derivative, morphine) is used to make heroin, the most abused of the narcotics.
Signs of opium use include constricted pupils, droopy eyelids, watery eyes, clammy or itchy skin, loss of appetite, sniffles, cough, nausea, lethargy, drowsiness, and nodding. Other general effects include lowered heart rate, blood pressure, and respiratory rate; nausea, drowsiness, poor concentration, lowered body temperature, decreased appetite, decreased sexual drive, and intense (but short) euphoria. Effects of long-term use include physical and psychological dependence, addiction and physical tolerance; mood swings, severe constipation, menstrual irregularities, lung damage, skin infections, seizures, unconsciousness, and coma.
References:
1: European Monitoring Centre for Drugs and Drug Addictions, The State of the Drugs Problem in Europe, ISBN 92-9168-227-6, 2005.
Heroin
Heroin, an illegal narcotic, is the most powerful of the opiates. Heroin is derived from morphine, one of the major constituents of the opium poppy plant. Pure heroin is a white powder but due to variations in processing the color may vary from white to dark brown. Additives such as sugar, starch, powdered milk, and quinine also play a part in heroin variation. Strychnine and other poisons have been reportedly mixed with heroin, adding to the unpredictability and risk associated with heroin use. Mexican black tar heroin is another form of heroin - it is a solid, dark brown substance. Street terms for heroin include smack, H, skag, thunder and junk.
References:
1, 2: NDIC, National Drug Threat Assessment, January 2006.
3: European Monitoring Centre for Drugs and Drug Addiction, The State of the Drugs Problem in Europe, ISBN 92-9168-227-6, 2005.
Black tar heroin
Black tar heroin has become increasingly available in the Western United States. Most of the black tar heroin consumed in the U.S. is produced in Mexico.
The color and consistency of black tar heroin results from the crude processing methods used to illicitly manufacture the substance. Black tar heroin may be sticky, like roofing tar or hard like coal, and its color may vary from dark brown to black. It is often sold on the street in its tar-like state at purities ranging from twenty to eighty percent.
References:
1: National Institute on Drug Abuse Research Report: Heroin Abuse and Addiction, NIH Publication No. 00-4165, September 2000.
2: NDIC, National Drug Threat Assessment, January 2006.
3: European Monitoring Centre for Drugs and Drug Addiction, The State of the Drugs Problem in Europe, ISBN 92-9168-227-62005.
The effects of heroin use
The initial and short term effects of heroin include a “rush”, a feeling of euphoria, suppression of pain, depressed respiratory rate, clouded mental functioning, and nausea or vomiting. Other effects include scarred or collapsed veins, bacterial infections of the blood vessels and heart valves, abscesses, liver or kidney disease, lung complications, infectious disease, arthritis, and pulmonary complication (including various types of pneumonia), possible fatal overdose, and possible spontaneous abortion in women who are pregnant. Long term effects include addiction, tolerance, and physical dependence. Withdrawal symptoms include restlessness, muscle and bone pain, insomnia, diarrhea, vomiting, cold flashes, and kicking movements. Withdrawal effects can occur within as little as a few hours in regular heroin users.
References:
1: European Monitoring Centre for Drugs and Drug Addiction, The State of the Drugs Problem in the European Union and Norway, ISBN 92-9168-199-7, 2004.
2: NIDA, National Drug Threat Assessment, January 2006
HALLUCINOGENS & DISSOCIATIVE DRUGS
LSD
Street terms for LSD include acid, boomers, microdot, cube, trips, tabs, doses, hits, dots
LSD, (lysergic acid diethylamide), is the most potent and highly studied hallucinogen known to man. Originally synthesized in 1938 at Basle, Switzerland by Dr. Albert Hoffman, its hallucinogenic effects were unknown until 1943 when Hoffman accidentally consumed some of the LSD
Hallucinogenic drugs have played a role in human life for thousands of years. Cultures from the tropics to the arctic have used plants to induce states of detachment from reality and to precipitate “visions” thought to provide mystical insight. These plants contain chemical compounds, such as mescaline, psilocybin, and ibogaine, that are structurally similar to serotonin, and they produce their effects by disrupting normal functioning of the serotonin system
LSD is usually produced from lysergic acid, which is made from ergotamine tartrate, a substance derived from an ergot fungus on rye, or from lysergic acid amide, a chemical found in morning glory seeds. Although theoretically possible, the manufacture of LSD from morning glory seeds is not economically feasible and these seeds never have been found to be a successful starting material for LSD production. Ergotamine tartrate used in clandestine LSD laboratories is believed to be acquired from sources in Europe, Mexico, Costa Rica, and Africa
The effects of LSD are unpredictable. The effects depend on the amount taken, the user’s personality, mood, and expectations and the surroundings in which the drug is used. The average effective oral dose is from 20 to 80 micrograms with the effects lasting two to three hours. With a larger dose, the effects can last ten to twelve hours. Typically, the user feels the first effects of the drug 30 to 90 minutes after taking it.
Most users of LSD voluntarily decrease or stop its use over time LSD is not considered an addictive drug since it does not produce compulsive drug-seeking behavior as do cocaine, amphetamine, heroin, alcohol, and nicotine. However, like many of the addictive drugs, LSD produces tolerance, so some users who take the drug repeatedly must take progressively higher doses to achieve the state of intoxication that they had previously achieved. This is an extremely dangerous practice, given the unpredictability of LSD.
Signs of LSD use include dilated pupils, sweating, dry mouth, abnormal laughter, distracted persona, and rapid reflexes. Other general effects include varying degrees of illusions, hallucinations, synesthesia, disorientation, impaired coordination, higher body temperature, loss of appetite, sleeplessness, tremors, delusions and confusion. LSD can cause elevated heart rate, blood pressure, extreme mood swings and impaired short-term memory. The user’s sense of time and self changes and sensations may seem to “cross over”, giving the user the feeling of hearing colors and seeing sounds. These changes can be frightening and can cause panic. Possible long-term effects include physical tolerance and psychological dependence (and possible psychosis), prolonged depression, anxiety, and flashbacks.
DOI
DOI (2,5-dimethoxy-4-iodoamphetamine), a hallucinogenic phenethylamine similar to 2C-B or DOM, has been appearing on college campuses in the Midwestern United States. The hallucinogenic effects are similar to those of LSD and DOI is being distributed like LSD: on paper squares or in tablet form
PCP
PCP (phencyclidine) is a dissociative anesthetic and has many of the same effects as LSD, but can be much more dangerous. In the 1950s, PCP was investigated as an anesthetic, but due to its severe side effects, its development for human use was discontinued. PCP is known for inducing violent behavior and causing negative physical reactions such as seizures and coma. There is no way to predict who will have a bad reaction to the drug. Maybe this is because PCP has so many faces – it acts as a hallucinogen, stimulant, depressant, and anesthetic – all at the same time
In its original state, PCP is a white crystalline powder. Dipping a cigarette or marijuana joint (or other leafy material such as parsley, mint, and oregano) into liquid PCP is its most common use. PCP is also manufactured into capsules or tablets. It’s most common form, a liquid, looks like apple juice. When something is dipped in PCP, it is difficult to see it: the best way to tell if something has been dipped in PCP is to smell it. PCP has a distinct chemical smell.
Signs of PCP use include eye fluttering, sweating, flushed skin, drooling, numbness, blurred vision, and garbled speech. Other general effects include varying degrees of illusions, hallucinations, synesthesia, disorientation, impaired coordination, confusion, agitation, coma, altered state of consciousness, stupor, convulsions, and unresponsiveness. PCP decreases heart rate, blood pressure, and body temperature. PCP is also widely known for causing violent experiences (“bad trips”). Long-term effects include physical tolerance and psychological dependence (and possible psychosis). Prolonged depression, anxiety, and flashbacks are also attributed to PCP use.
PCP can cause effects that mimic the full range of symptoms of schizophrenia, such as delusions, paranoia, disordered thinking, a sensation of distance from one’s environment, and catatonia. Speech is often sparse and garbled. People who use PCP for long periods report memory loss, difficulties with speech and thinking, depression, and weight loss. These symptoms can persist up to a year after cessation of PCP use. Mood disorders also have been reported. PCP has sedative effects, and interactions with other central nervous system depressants, such as alcohol and benzodiazepines, can lead to coma or accidental overdose. 1
References:
1: NIDA InfoFacts: PCP, April 2004
KETAMINE
Ketamine (enzoyle hydrochloride) is a preoperative anesthetic that is used in veterinary medicine. Ketamine is considered a “dissociative anesthetic”, (like PCP) because it causes a user to feel detached from his or her environment. Ketamine also has both analgesic (pain relief) and amnesic (memory loss) properties. Like GHB and Rohypnol®, Ketamine has been used in drug facilitated sexual assaults. As with GHB, enzoyle rapidly metabolizes in the body and can be difficult to detect with drug tests 48 hours after it is taken. Ketamine is manufactured commercially as a powder or liquid.
Signs of enzoyle use include dilated pupils, sweating, slurred speech, and disorientation. Other general effects include a depressed respiratory rate, nausea, loss of coordination, temporary amnesia, hallucinations, paranoia, coma, and death. Long term effects of use include flashbacks, physical tolerance, physical and/or psychological dependence. Signs of an enzoyle overdose include vomiting and convulsions.
HALLUCINOGENIC MUSHROOMS
Street terms for hallucinogenic mushrooms include mushrooms, caps, magic mushrooms.
There are more then 2500 mushroom varieties grown in the world today. Of these, several species have hallucinogenic properties. They are often referred to as “magic mushrooms.” Some hallucinogenic mushrooms are domestically gown indoors or harvested in the wild. Others are smuggled from Mexico and Central America.
Hallucinogenic mushrooms contain two psychoactive ingredients: psilocybin and psilocin. Psilocybin is the main psychoactive ingredient and psilocin is found in smaller amounts, yet is more potent. When hallucinogenic mushrooms are ingested, the psilocybin is metabolized into psilocin.
Like peyote, mushrooms have been used in native rites for centuries. Dried mushrooms contain about 0.2 to 0.4 percent psilocybin and only trace amounts of psilocin. The hallucinogenic dose of both substances is about 4 to 8 milligrams or about 2 grams of mushrooms. Effects last for six to eight hours. Both psilocybin and psilocin can be produced synthetically. Mushrooms are eaten, brewed in tea, dried and put in capsule form, or dried and laced with cigarettes or marijuana joints for their hallucinogenic effects.
The effects produced by consuming preparations of dried or brewed mushrooms are far less predictable (than LSD) and largely depend on the particular mushrooms used and the age and preservation of the extract. There are many species of “magic” mushrooms that contain varying amounts of tryptamines, as well as uncertain amounts of other chemicals. As a consequence, the hallucinogenic activity, as well as the extent of toxicity produced by various plant samples, is often unknown. 1
Signs of mushroom use include dilated pupils, aggressive behavior, and confusion. Other general effects include varying degrees of illusions, hallucinations, synesthesia, disorientation, impaired coordination, and confusion. Psilocybin use causes elevated heart rate, blood pressure, and body temperature. A mushroom experience is similar to a mild LSD experience, but less acute hallucinations and high durations are attributed to psilocybin. Possible long-term effects of use include physical tolerance and psychological dependence (and possible psychosis).
Psilocybin is cultivated in indoor and outdoor grow sites in most regions of the country, particularly in the Pacific region. Local independent indoor cultivation appears to be increasing, likely aided by an increase in the availability of mail order cultivation kits and indoor cultivation information available via the internet. 2
References:
1: DEA
2: NDIC, National Drug Threat Assessment, April 2004.
MESCALINE
Mescaline (3, 4, 5-trimethoxyphenethylamine) is the active hallucinogenic ingredient in both the peyote and san pedro cacti. Mescaline can also be produced synthetically. The hallucinogenic dose of mescaline is about 0.3 to 0.5 grams and lasts about 12 hours.
Street terms for mescaline include buttons, cactus, nubs, tops, seni, britton, half moon and hikori.
Signs of mescaline use include dilated pupils, sweating, garbled speech, and disorientation. Other general effects include varying degrees of illusions, hallucinations, synesthesia, disorientation, impaired coordination, and confusion. Like LSD, mushrooms, and ecstasy, mescaline causes elevated heart rate, blood pressure, and body temperature. Less acute hallucinations and high durations of effects are attributed to mescaline. Possible long-term effects of use include physical tolerance and psychological dependence (and possible psychosis),.
PEYOTE CACTUS
Peyote is a small, spineless cactus, Lophophora williamsii. From earliest recoded time, peyote has been used by natives in northern Mexico and the southwestern United States as a part of their religious rites. The top of the cactus above ground – also referred to as the crown – consists of disc-shaped buttons that are cut from the roots and dried. These buttons are generally chewed or soaked in water to produce an intoxicating liquid.
SAN PEDRO CACTUS
The San Pedro cactus, Trichocereus pachanoi, is native to the high Andes in Peru, South America. Like peyote, its principle active ingredient is mescaline. The cactus can be purchased almost anywhere and is readily available on the Internet. Internet sites usually provide warnings that they do not condone, support or encourage the illegal use of their products, yet they provide instructions for use, positive “customer” testimonials and sell them for what they describe as a “small” price.
DEPRESSANTS
GHB & GHB ANALOGS
GHB is a synthetic depressant that is produced in clandestine labs, usually with kits or ingredients sold on the internet. GHB and its analogs, GHB (gamma-butyrolactone) and BD (1,4 butanediol) have become the subject of rising concern due to their use as date rape drugs and their dangerous side effects.
GHB analogs (GBL and BD) are solvents that have chemical structures that closely resemble that of GHB. These analogs metabolize into GHB upon ingestion, and thus produce the same effects of GHB. GHB analogs have been appearing in the illegal drug market as GHB substitutes. GHB analogs are available legally as industrial solvents used to produce polyurethane, pesticides, elastic fibers, pharmaceuticals, coatings on metal or plastic, and other products. They also are sold illicitly as supplements for bodybuilding, fat loss, reversal of baldness, improved eyesight, and to combat aging, depression, drug addiction, and insomnia. GHB product names include Longevity, Revivarant, G.H. Revitalizer, Gamma G, Blue Nitro, Insom-X, Remforce, Firewater and Invigorate. Products that contain BD include Revitalize Plus, Serenity, Enliven, GHRE, SomatoPro, NRG3, Thunder Nectar and Weight Belt Cleaner.1
GHB is considered a date rape drug because it is virtually undetectable (although it has a salty taste) when mixed with liquids and a victim may not be able to detect it. GHB and its analogs are also cleared from the body relatively quickly, so it is sometimes difficult to detect them in emergency rooms and other treatment facilities. GHB and its analogs are also not detectable in routine blood and urine screens – a GHB screen needs to be requested in possible rape situations. Detectable levels of GHB remain in the urine for 8-12 hours, and 4-8 hours in the blood (after ingestion). In 2002, law enforcement agencies in every region of the United States reported that GHB appeared to have surpassed Rohypnol® as the most common substance in drug-facilitated sexual assault.
References:
1: U.S. FDA Report: Serious Adverse Events Associated with Dietary Supplements Containing GBL, GHB, or BD, August 1999.
GHB is often taken after a night of partying to come down off a high. The drugs often have a salty taste. Because of the salty taste, they are often mixed in a flavored beverage. They are often used in combination with alcohol, making them even more dangerous. GHB and its analogs act quickly in the body. When taken in overdose unconsciousness can occur after 15 minutes, and coma within 30 to 40 minutes. Overdose frequently requires emergency room care, including intensive care for respiratory depression and coma. Most individuals regain consciousness within two to four hours.
General effects of GHB intoxication include a drunken-like state exhibiting nausea, drowsiness, dizziness, confusion, muscle relaxation, impaired coordination, lowered blood pressure, lowered heart rate, and lowered respiratory rate. High doses of GHB produce memory loss, sedation, seizures, coma, and death. Long term effects include physical tolerance as well as psychological and physical dependence. Withdrawal symptoms include insomnia, tremors, tachycardia (abnormally fast heart rate), delirium, and agitation.
STEROIDS
Steroid use and abuse has been a topic of concern for many years. Steroids are legally prescribed to treat those with low testosterone levels and to treat body wasting in patients with AIDS and other diseases. These drugs are also used illegally by athletes, body builders and others who claim that the drugs give them a competitive advantage or improve their physical appearance.
Anabolic steroids are any drug or hormonal substance chemically and pharmacologically related to testosterone (other than estrogens, progestins, and corticosteroids), that promotes muscle growth. Most illicit steroids are sold at gyms, competitions and through mail order operations. For the most part, these substances are smuggled into the United States.
The major side effects from abusing anabolic steroids can include liver tumors and cancer, jaundice (yellowish pigmentation of skin, tissues, and body fluids), and decreases in HDL (good cholesterol). Other side effects include kidney tumors, severe acne, and trembling.
In addition, there are some gender-specific side effects:
- For men – shrinking of the testicles, reduced sperm count, infertility baldness, development of breasts, increased risk for prostate cancer
- For women – growth of facial hair, male pattern baldness, changes in or cessation of the menstrual cycle, enlargement of the clitoris, deepened voice
- For adolescents – growth halted prematurely through premature skeletal maturation and accelerated puberty changes. This means that adolescents risk remaining short for the remainder of their lives if they take anabolic steroids before the typical adolescent growth spurt. 3
Anabolic steroids were developed in the late 1930s primarily to treat hypogonadism, a condition in which the testes do not produce sufficient testosterone for normal growth, development and sexual functioning. 2
References:
2: NIDA, Research Report: Anabolic Steroid Abuse, NIH Publication No. 00-372, April, 2000.
3: NIDA, InfoFacts: Steroids (Anabolic-Androgenic), March 2005.
INHALANTS
A common misconception about inhalant “sniffing”, “snorting”, “bagging” (fumes inhaled from a plastic bag), or “huffing” (inhalant-soaked rag in the mouth) is that it is a childish fad to be equated with youthful experiments with cigarettes.
But inhalant abuse is deadly serious and one of the most dangerous of “experimental behaviors”. Sniffing volatile solvents, which includes most inhalants, can cause severe damage to the brain and nervous system. By starving the body of oxygen or forcing the heart to beat more rapidly and erratically, inhalants can kill sniffers, most of whom are adolescents.
Inhalant abuse came to public attention in the 1950s when the news media reported that young people who were seeking a cheap “high” were sniffing glue. The term “glue sniffing” is still widely used, often to include inhalation of a broad range of common products besides glue.
Although different in makeup, nearly all abused inhalants produce effects similar to anesthetics, which act to slow down the body’s functions. When inhaled via the nose or mouth in sufficient concentrations, inhalants can cause intoxicating effects that can last a few minutes or several hours if taken repeatedly. Initially, users may feel slightly stimulated; with successive inhalations they may feel less inhibited and less in control; finally, a user can lose consciousness.
Sniffing highly concentrated amounts of the chemicals in solvents or aerosol sprays can directly induce heart failure and death. This is especially common from the abuse of fluorocarbon and butane-type gases. High concentrations of inhalants also cause death from suffocating by displacing oxygen in the lungs and then in the central nervous system causing breathing to cease.
Typical inhalants include airplane glue, rubber, cements, nail polish remover, spray paint, whip cream cans, correction fluid, gasoline, nitrous oxide, paint thinner, air freshener, butane fuels, wax removers, hair spray, analgesic sprays, deodorants, air freshener, lighter fuels, PVC cement, cleaning fluid, spot remover and degreaser.
EFFECTS OF INHALANT ABUSE
Possible effects include sudden death (presumably from cardiac arrest), suffocation (typically seen with inhalant users who use bags), asphyxia (solvent gases can significantly limit available oxygen in the air, causing breathing to stop), visual hallucinations and severe mood swings, numbness and tingling of the hands and feet, loss of muscle control, slurred speech, headache, muscle weakness, abdominal pain, decrease or loss of sense of smell, nausea and nosebleeds, hepatitis, violent behavior, irregular heartbeat, liver, lung, and kidney impairment, brain damage, nervous system damage, dangerous chemical imbalances in the body, and involuntary passing of urine and feces.
Chemical Specific Drug Reactions: 3
Amyl nitrate, butyl nitrite
- Sudden sniffing death syndrome, suppressed immunologic function, injury to red blood cells (interfering with oxygen supply to vital tissues).
Benzene (found in gasoline)
- Bone marrow injury; impaired immunologic function, increased risk of leukemia, reproductive system toxicity.
Butane, propane (lighter fluid, hair and paint sprays)
- Sudden sniffing death syndrome via cardiac effects; serious burn injuries (flammable).
Freon (refrigerant and aerosol propellant)
- Sudden sniffing death syndrome, respiratory obstruction and death (from sudden cooling/cold injury to airways), and liver damage.
Methylene chloride (pain thinners and removers, degreasers)
- Reduction of oxygen-carrying capacity of blood, changes to the heart muscle and heartbeat.
Nitrous oxide (laughing gas), hexane
- Death from lack of oxygen to the brain, altered perception and motor coordination, loss of sensation, limb spasms, blackouts caused by blood pressure changes, and depression of heart muscle functioning.
Toluene (gasoline, paint thinners and removers, correction fluid)
- Brain damage (loss of brain tissue mass, impaired cognition, gait disturbance, loss of coordination, loss of equilibrium, limb spasms, hearing and vision loss), liver and kidney damage.
Trichlorethylene (spot removers, degreasers)
- Sudden sniffing death syndrome, cirrhosis of the liver, reproductive complications, hearing, and vision damage.
Slang terms;2
Air blast, Ames (amyl nitrite), Amys (amyl nitrite), Aroma of men (isobutyl nitrite), Bagging (using inhalants), Bolt (isobutyl nitrite), Boppers (amyl nitrite), Buzz bomb (nitrous oxide), Climax (isobutyl nitrite), Discorama, Glading (using inhalant), Gluey (one who sniffs of inhales glue), Hardware (isobutyl nitrate), Hippie crack, Honey oil, Huff, Huffing (sniffing an inhalant), Kick, Laughing gas (nitrous oxide), Medusa, Moon Gas, Oz, Pearls (amyl nitrite), Poor man’s pot, Poppers (isobutyl nitrite, amyl nitrite), Quicksilver (isobutyl nitrite), Rush (isobutyl nitrite), Shoot the breeze (nitrous oxide), Snappers (isobutyl nitrite), Snorting (using inhalant), Thrust (isobutyl nitrite), Toncho (octane booster), Whippets (nitrous oxide), Whiteout (isobutyl nitrite).
References:
1: NDIC, National Drug Threat Assessment, April 2004.
2: Drug Policy Information Clearinghouse.
3: NIDA Research Report: Inhalant Abuse, NIH Publication No. 00-3818, March 2004.
OTHER DRUGS
ALKYL NITRATES (“Poppers”, Snappers”)
Street terms for alkyl nitrates include Ram, Rush, Thrust, Rock Hard, Kix, TNT, Liquid Gold.
Poppers are small bottles filled with liquid alkyl nitraies (amyl nitrite, butyl nitrite, isobutyl nitrite). Once used to ease chest pain (angina) alkyl nitrates are now used recreationally as an inhalant.
Alkyl nitrites are usually inhaled from a bottle or through a cloth and produce a short but powerful high which lasts from 2-5 minutes. Poppers have a sweet smell when first opened, but after time the smell turns sour. If swallowed, alkyl nitrites can be poisonous.
The most common side effect of using alkyl nitrites is a powerful headache but others include rashes around the nose and mouth and a flushed face. Risks of use include loss of consciousness and heart attack. People with glaucoma, anemia, heart problems or high blood pressure should not take alkyl nitrites. When in contact with skin, liquid nitrites can burn.
Nitrites often are considered a special class of inhalants. Unlike most other inhalants, which act directly on the central nervous system (CNS), nitrites act primarily to dilate blood vessels and relax the muscles. And while other inhalants are used to alter mood, nitrites are used primarily as sexual enhancers.
VIAGRA®
Some people have been using Viagra in combination with “Poppers”. Pfizer, Inc., the makers of Viagra, has released a warning about the combined use of Viagra with “Poppers” or other illicit drugs. Deaths have been reported.
SALVIA DIVINORUM
Salvia Divinorum is a perennial herb in the mint family that resembles sage. The plant is native to certain areas of the Sierra Mazateca region of Oaxaca, Mexico, but can be grown in any humid, semitropical climate as well as indoors. Within the United States, the plant primarily is cultivated in California and Hawaii. It grows in large clusters and reaches over 3 feet in height. Salvinorin A is the active component of Salvia Divinorum.
At the is time there is no accepted medical use for Salvia Divinorum, however, Mazatec Indians in Mexico use the plant in traditional healing ceremonies and to induce visions. The manner in which Salvia Divinorum interacts with the brain to produce its hallucinogenic effect remains unclear. The hallucinogenic effects generally last 1 hour or less unlike other hallucinogens like LSD and PCP. High doses of the drug can cause unconsciousness and short-term memory loss.
The long-term effects of Salvia Divinorum abuse are unknown, as medical studies undertaken to examine the drug’s physiological effects have focused only on short-term effects. However, information provided by users indicates that the negative long-term effects of Salvia Divinorum may be similar to those produced by other hallucinogens such as LSD including depression and schizophrenia. Some users also indicate that long-term abuse can cause hallucinogen persisting perception disorder, or “flash backs”.
A NOTE ABOUT “LEGAL HIGHS”
The popularity of “legal highs” sold online and in headshops has been increasing. Because these products are new, they have yet to be regulated and reliable information about their effects is unavailable. Kratom, mitragyna speciosa, a plant native to Asia has been banned in Thailand and Australia. Its euphoric effects are purportedly similar to a combination of heroin and cocaine. Fly Agaric, amanita muscaria, is a spotted mushroom with reported mild hallucinogenic effects. Piperazines, sold a “P.E.P. Pills”, belong to the same class of drugs as Viagra and reportedly have effects similar to those of ecstasy (MDMA).
References:
1: NDIC, Information Bulletin: Saliva Divinorum, Document ID 2003-L0424-003, April 2003.
MARIJUANA
Marijuana is the most frequently used illicit drug in the world today. The term marijuana, as commonly used, refers to the leaves and flowering buds of cannabis sativa, the hemp plant.
The plant, cannabis sativa, contains chemicals called “enzoylecgon.” THC (delta-9-tetrhydrocannabinol) is the enzoylecgo believed to be responsible for the psychoactive effects of cannabis.
THC can be found in all parts of the cannabis plant, including hemp. This is why hemp is regulated carefully – some hemp products such as clothing, rope, yarn, lotion and soap are legal products because they do not cause THC to enter the human body.
Marijuana varies significantly in its potency, depending on the source and selection of plant materials. The form of marijuana known as sinsemilla (Spanish, sin semilla: without seed), derived from the unpollinated female cannabis plant, is preferred for its high THC content. Marijuana advancements in plant selection and cultivation have resulted in highly potent domestic varieties. In 1974, the average THC content of illicit marijuana was less than one percent. In 2002, the average THC level was more than 6 percent. Sinsemilla potency increased in the past two decades from 6 percent to more than 13 percent, with some samples containing THC levels of up to 33 percent.
References:
1: NDIC: National Drug Threat Assessment, February 2005.
2: NDIC: National Drug Threat Assessment, April 2004.
3: European Monitoring Centre for Drugs and Drug Addiction, The State of the Drugs Problem in the European Union and Norway, ISBN 92-9168-199-7, 2004.
4: European Monitoring Centre for Drugs and Drug Addiction, The State of the Drugs Problem in Europe, ISBN 92-9168-227-6, 2005.
5: NDIC, National Drug Threat Assessment, January 2006.
6: ONDCP, What Americans Need To Know about Marijuana, October 2003.
THE EFFECTS
Short-term effects of marijuana use include impaired short-term memory, impaired attention, judgment, impaired coordination and balance, increased heart rate, bloodshot eyes, dry mouth, and increased appetite (“the munchies”). Long term use can lead to addiction, paranoia, anxiety, impaired learning skills and long-term memory difficulties. Medical complications include an increased risk of chronic cough, bronchitis, and emphysema; increased risk of cancer of the head, neck and lungs; a decrease in testosterone levels and lower sperm counts for men; an increase in testosterone levels for women and increased risk of infertility.
Note: Need a disclaimer e.g. information is not all inclusive should not be used a substitute for professional medical advice. Also, all registered Trademarks should be listed and the Trademark ownership acknowledged, may also wish to include a disclaimer acknowledging that these drugs are legal prescription drugs used outside of the context of their intended use and the manufacturers instructions for use
Top
Drug Abuse in the Workplace
- Coming Soon
- 2006 U.S. Worker Substance Use and Workplace Policies and Programs
Coming Soon
Top
Scientific Research
Oral fluid collection: The neglected variable in oral fluid testing
Dennis J. Crouch a,b,c,*
A Research Associate Professor, University of Utah, Salt Lake City, UT 84112, USA
b Co-Director, Center for Human Toxicology, Salt Lake City, UT 84112, USA, Director, Sports Medicine Research & Testing
b Laboratory, Salt Lake City, UT 84112, USA Received 8 October 2004; received in revised form 16 February 2005; accepted 16 February 2005
Abstract
The potential to use oral fluid as a drug-testing specimen has been the subject of considerable scientific interest. The ease with which specimens can be collected and the potential for oral fluid (OF) drug concentrations to reflect blood–drug concentrations make it a potentially valuable specimen in clinical as well as forensic settings. However, the possible effects of the OF collection process on drug detection and quantification has often been over looked. Several studies have documented that drug-contamination of the oral cavity may skew oral fluid/blood drug ratios and confound interpretation when drugs are smoked, insufflated or ingested orally. OF pH is predicted to have an effect on the concentration of drugs in OF. However, in a controlled clinical study, the effect of pH was less than that of collection technique. Mean codeine OF concentrations in specimens collected a non-stimulating control method were 3.6 times higher than those in OF collected after acidic stimulation. Mean codeine concentrations were 50%lower than control using mechanical stimulation and 77% of control using commercial collection devices
Several factors should be considered if a commercial OF collection device is used. In vitro collection experiments demonstrated that the mean collection volume varied between devices from 0.82 to 1.86 mL. The percentage of the collected volume that could be recovered from the device varied from 18% to 83%. In vitro experiments demonstrated considerable variation in the recovery of amphetamines (16–59%), opiates (33–50%), cocaine and enzoylecgonine (61–97%), carboxy-THC (0–53%) and PCP (9–56%). Less variation in collection volume, volume recovered and drug recovery was observed intra-device. The THC stability was evaluated in a common commercial collection protocol. Samples in the collection buffer were relatively stable for 6 weeks when stored frozen. However, stability was marginal under refrigerated conditions and poor at room temperature. Very little has been published on the efficacy of using IgG concentration, or any other endogenous marker, as a measure of OF specimen validity. Preliminary rinsing experiments with moderate (50mL and 2 _ 50mL) volumes of water did not reduce the OF IgG concentration below proposed specimen validity criteria. In summary, obvious and more subtle variables in the OF collection may have pronounced effects on OF–drug concentrations. This has rarely been acknowledged in the literature, but should to be considered in OF drug testing, interpretation of OF–drug results and future research studies.
2005 Elsevier Ireland Ltd. All rights reserved. www.elsevier.com
Cognition and motor control as a function of _9-THC concentration in serum and oral fluid: Limits of impairment
J.G. Ramaekers a,∗, M.R. Moeller b, P. van Ruitenbeek a, E.L. Theunissen a, E. Schneider c, G. Kauert d
a Experimental Psychopharmacology Unit, Department of Neurocognition, Faculty of Psychology,
Maastricht University, 6200 MD Maastricht, The Netherlands
b Unikliniken des Saarlandes, Homburg, Germany
c Landeskriminalamt, Kriminaltechnisches Institut, Baden-W¨urttemberg, Germany
d Department of Forensic Toxicology, Institute of Legal Medicine, Goethe University of Frankfurt, Germany
Received 14 December 2005; received in revised form 22 March 2006; accepted 23 March 2006
Abstract
Cannabis use has been associated with increased risk of becoming involved in traffic accidents; however, the relation between THC concentration and driver impairment is relatively obscure. The present study was designed to define performance impairment as a function of THC in serum and oral fluid in order to provide a scientific framework to the development of per se limits for driving under the influence of cannabis. Twenty recreational users of cannabis participated in a double-blind, placebo-controlled, three-way cross-over study. Subjects were administered single doses of 0, 250 and 500 _g/kg THC by smoking. Performance tests measuring skills related to driving were conducted at regular intervals between 15 min and 6 h post smoking and included measures of perceptual-motor control (Critical tracking task), motor impulsivity (Stop signal task) and cognitive function (Tower of London). Blood and oral fluid were collected throughout testing. Results showed a strong and linear relation between THC in serum and oral fluid. Linear relations between magnitude of performance impairment and THC in oral fluid and serum, however, were low. A more promising way to define threshold levels of impairment was found by comparing the proportion of observations showing impairment or no impairment as a function of THC concentration. The proportion of observations showing impairment progressively increased as a function of serum THC in every task. Binomial tests showed an initial and significant shift toward impairment in the Critical tracking task for serum THC concentrations between 2 and 5ng/ml. At concentrations between 5 and 10ng/ml approximately 75–90% of the observations were indicative of significant impairment in every performance test. At THC concentrations >30 ng/ml the proportion of observations indicative of significant impairment increased to a full 100% in every performance tests. It is concluded that serum THC concentrations between 2 and 5 ng/ml establish the lower and upper range of a THC limit for impairment.
© 2006 Elsevier Ireland Ltd. All rights reserved. www.elsevier.com
Oral fluid testing for cannabis: On-site OraLine1
IV s.a.t. device versus GC/MS
Vincent Cirimele a,*, Marion Villain a, Patrick Mura b, Marc Bernard c, Pascal Kintz a
a Laboratoire ChemTox, 3, rue Gru¨ninger, F-67400 Illkirch, France
b Laboratoire de biochimie, Poitiers, France
c Urgences Me´dico-judiciaires, Compie`gne, France
Abstract
Saliva or ‘‘oral fluid’’ has been presented as an alternative matrix to document drug use. The non-invasive collection of a saliva sample, which is relatively easy to perform and can be achieved under close supervision, is one of the most important benefits in a driving under the influence situation. Moreover, the presence of D9-tetrahydrocannabinol (THC) in oral fluid is a better indication of recent use than when 11-nor-D9-tetrahydrocannabinol-9-carboxylic acid (THC-COOH) is detected in urine, so there is a higher probability that the subject is experiencing pharmacological effects at the time of sampling. In the first part of the study, 27 drug addicts were tested for the presence of THC using the OraLine1 IV s.a.t. device to establish the potential of this new on-site DOA detection technique. In parallel, oral fluid was collected with the Intercept1 DOA Oral Specimen Collection device and tested for THC by gas chromatography mass spectrometry (GC/MS) after methylation for THC (limit of quantitation: 1 ng/mL). The OraLine device correctly identified nine saliva specimens positive for cannabis with THC concentrations ranging from 3 to 265ng/mL, but remained negative in four other samples where low THC concentrations were detected by GC/MS (1–13 ng/mL). One false positive was noted. Secondly, two male subjects were screened in saliva using the OraLine1 and Intercept1 devices after consumption of a single cannabis cigarette containing 25 mg of THC. Saliva was first tested with the OraLine1 device and then collected with the Intercept1 device for GC/MS confirmation. In one subject, the OraLine1 on-site test was positive for THC for 2 h following drug intake with THC concentrations decreasing from 196 to 16 ng/mL, while the test remained positive for 1.5 h for the second subject (THC concentrations ranging from 199 to 11 ng/mL). These preliminary results obtained with the OraLine1 IV s.a.t. device indicate more encouraging data for the detection of THC using on-site tests than previous evaluations.
© 2006 Elsevier Ireland Ltd. All rights reserved. www.elsevier.com
Note: Obtain written confirmation from Elsevier Press that the company may list these abstracts on their website with links back to Elsevier Press for persons wishing to purchase the full published paper. These abstracts are in the public domain hence Elsevier Press do not have any basis to prevent the posting of the abstract however better to take the precaution rather than getting pinged for copywrite infringement.